Pharmacogenomics and Clinical Genomics

Pharmacogenomics  is the study of the role of genetics in drug response. Computational advances in Pharmacogenomics has proven to be a blessing in research. A large amount of research in the biomedical sciences regarding Pharmacogenomics as of late stems from combinatorial chemistry,[53] genomic mining, omic technologies and high throughput screening. In order for the field to grow rich knowledge enterprises and business must work more closely together and adopt simulation strategies. Major Universities dealing Pharmacogenomics are:  Harvard University, US, , University of Cambridge, UK, National University of Singapore, Singapore, University of Oxford, UK, Karolinska Institute, Sweden, Monash University, Australia, Imperial College London, UK, University of Tokyo, Japan, University of Melbourne, Australia, University of Michigan, US.

  • Translational Pharmacogenomics
  • Applications of NGS to Pharmacogenomics
  • Nutrigenomics
  • Toxicogenomics
  • Biomarker translation and testing
  • Biological and small molecule therapeutics
  • Molecular-targeted interventions including gene therapy
  • Molecular diagnostics
  • Pharmacogenomics
  • Cancer Pharmacogenomics
  • Pharmacogenitics & Individualized therapy
  • Pharmacogenomics in Clinical Therapeutics

Related Conference of Pharmacogenomics and Clinical Genomics

October 17-18, 2022

21st International Conference on Structural Biology

Barcelona, Spain
November 15-16, 2022

3rd Experts Meeting on Plant, Cellular and Molecular Biology

Budapest, Hungary
November 21-22, 2022

4th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada
May 03-04, 2023

16th World Congress on Stem Cell Research

Paris, France
May 03-04, 2023

Global Conference on Cell and Gene Therapy

Paris, France

Pharmacogenomics and Clinical Genomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in